- RFA-DK-25-013, Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed)
- RFA-MD-24-005 Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 – Clinical Trials Not Allowed)
- NOT-AI-23-046 HIV Cure-Related Research in Diverse Populations (R01; R21) – Sponsored by NIAID, NIMH, and NIDDK. Standard AIDS receipt dates apply.
- Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01; R21): Standard AIDS receipt dates.
- ACTG Small Clinical Trials Advancing HIV Remission and Cure RFA: Letter of Intent REQUIRED. Next LOI due date September 5th for applications due October 1st.
- NIAID Research Opportunities for New and “At-Risk” Investigators to Promote Workforce Diversity (R01): Standard AIDS receipt dates.
- NIAID New Innovators Awards (DP2): $300,000 direct costs per year. October 11, 2024; October 10, 2025 receipt dates.
- U.S. – Japan Cooperative Medical Sciences Program Collaborative Awards 2024: $60,000 to support a 2-year collaboration between early-career or female investigators in the U.S. and Japan. Title and abstracts due May 20, 2024.
- Japan Agency for Medical Research and Development (AMED) – FY2024 Advanced International Collaborative Research Program – Adopting Sustainable Partnerships for an Innovative Research Ecosystem (ASPIRE): 3-5 years of support for Japanese investigators collaborating with NIH-funded counterparts in the U.S. Applications due May 28, 2024.
- Notice of Special Interest: Women’s Health Research – Applications with HIV research are listed as an interest for NIAID and other ICs. NOT-OD-24-079: https://grants.nih.gov/grants/guide/notice-files/not-od-24-079.html